More positive news this morning on the Special Diabetes Program (SDP)! The Senate HELP Committee approved a 2-year renewal of the SDP at $170 million, plus an added 3 months, extending the program through December 2025! 1/3
"affordable for all. No one should ever be sick or die because they don't have access to affordable insulin. #InsulinAffordability is the entry point and I will keep fighting for Jackson and all other T1Ds." Join Brian in moving #ForwardAs1 for Jackson and the other (2/3)
Brian is a dedicated JDRF Advocacy leader and #T1D dad on a mission to drive us #FORWARD! "My son, Jackson, keeps me moving forward in the fight against T1D. An active 15 year old, Jackson is a two-sport athlete. The insulin that Jackson uses every day needs to be" (1/3)
It is long past time for Congress to act on a bipartisan basis to make this life-saving drug affordable for all – read our full statement and take action in support of the Affordable Insulin Now Act here: https://t.co/S6ftIXAC2C (3/3)
Joshua Davis, the young man with #T1D who joined the First Lady in the gallery, was one of the JDRF Children’s Congress delegates who called for action on this issue in 2017. (2/2)
JDRF is glad President Biden used the State of the Union to address the insulin affordability crisis, which has had devastating consequences in the diabetes community for far too long. (1/3)
@JDRF For far too long, the increasing cost of insulin has created a crisis for millions of Americans. We implore the current administration and members of Congress to act on a bipartisan basis to make this life-saving drug available for all #SOTU
President Biden says cutting the cost of prescription drugs is a key part of his plan to fight inflation, including capping the cost of insulin at $35 a month and allowing Medicare to negotiate lower prices, as the VA already does #SOTU2022
The FDA has authorized the Insulet Omnipod 5, the world’s first tubeless, wearable system for individuals 6 and older. It is the fourth artificial pancreas system on the market. Learn more about this exciting news here: https://t.co/fSkquM0XU0
The FDA has approved the Abbott FreeStyle Libre 2 iOS App, which will allow FreeStyle Libre 2 users to access glucose readings directly from their phones.
Learn more here: https://t.co/w3GqhXpNgc
Congratulations to the JDRF T1D Fund on their amazing progress. Thanks to the amazing work of the Fund, we are now closer than ever to curing #T1D with a strong and growing consortium life sciences investors and companies working towards this goal.
https://t.co/4SgIBp3am7